European Heart Journal Advance Access published online on August 5, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn363
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T
1 The Heart Centre, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, UK
2 Craigavon Cardiac Centre, Craigavon Area Hospital, Craigavon BT63 5QQ, Northern Ireland, UK
3 Nutrition and Metabolism Group, Centre for Clinical and Population Sciences, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK
Received 27 March 2008; revised 10 July 2008; accepted 17 July 2008.
* Corresponding author. Tel: +44 289 063 3714, Fax: +44 289 031 4169, Email: jennifer.adgey{at}belfasttrust.hscni.net
Aims: To evaluate the role of novel biomarkers in early detection of acute myocardial infarction (MI) in patients admitted with acute chest pain.
Methods and results: A prospective study of 664 patients presenting to two coronary care units with chest pain was conducted over 3 years from 2003. Patients were assessed on admission: clinical characteristics, ECG (electrocardiogram), renal function, cardiac troponin T (cTnT), heart fatty acid binding protein (H-FABP), glycogen phosphorylase-BB, NT-pro-brain natriuretic peptide, D-dimer, hsCRP (high sensitivity C-reactive protein), myeloperoxidase, matrix metalloproteinase-9, pregnancy associated plasma protein-A, soluble CD40 ligand. A
12 h cTnT sample was also obtained. MI was defined as cTnT
0.03 µg/L. In patients presenting <4 h of symptom onset, sensitivity of H-FABP for MI was significantly higher than admission cTnT (73 vs. 55%; P = 0.043). Specificity of H-FABP was 71%. None of the other biomarkers challenged cTnT. Combined use of H-FABP and cTnT (either one elevated initially) significantly improved the sensitivities of H-FABP or cTnT (85%; P
0.004). This combined approach also improved the negative predictive value, negative likelihood ratio, and the risk ratio.
Conclusion: Assessment of H-FABP within the first 4 h of symptoms is superior to cTnT for detection of MI, and is a useful additional biomarker for patients with acute chest pain.
Key Words: Acute myocardial infarction Diagnosis Biomarkers
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, S. Hartwiger, S. Biedert, N. Schaub, C. Buerge, M. Potocki, et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays N. Engl. J. Med., August 27, 2009; 361(9): 858 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shyamsundar, S. T. W. McKeown, C. M. O'Kane, T. R. Craig, V. Brown, D. R. Thickett, M. A. Matthay, C. C. Taggart, J. T. Backman, J. S. Elborn, et al. Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers Am. J. Respir. Crit. Care Med., June 15, 2009; 179(12): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gravning and J. Kjekshus The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatment Eur. Heart J., December 1, 2008; 29(23): 2827 - 2828. [Full Text] [PDF] |
||||


